Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
J Gen Virol ; 40(3): 695-9, 1978 Sep.
Article in English | MEDLINE | ID: mdl-690618

ABSTRACT

The association of newly synthesized vaccinia virus DNA with proteins in infected HeLa cells was followed. A shift from a high density to a low density complex occurred between 3 and 6 h after infection. This process was not affected by isatin beta thiosemicarbazone (IBT), an inhibitor of pox virus growth. At 22 h after infection in the absence of IBT, mature virions of high density were observed; however, in the presence of the drug, high density DNA-protein complexes, which lack the two main virus core polypeptides, were formed.


Subject(s)
DNA, Viral , Indoles/pharmacology , Isatin/pharmacology , Thiosemicarbazones/pharmacology , Vaccinia virus/drug effects , Viral Proteins , DNA, Viral/biosynthesis , HeLa Cells , Isatin/analogs & derivatives , Peptides/analysis , Vaccinia virus/growth & development , Vaccinia virus/metabolism , Viral Proteins/analysis
5.
J Gen Virol ; 32(2): 327-30, 1976 Aug.
Article in English | MEDLINE | ID: mdl-1018177

ABSTRACT

Virazole or Ribavirin (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide) inhibits the growth of vaccinia virus at a concentration ode to a certain extent in the presence of Virazole, the DNA fails to acquire resistance to deoxyribonuclease and virus particles are not formed. Reversibility of the antiviral effect occurs when the drug is washed out from the infected cultures or when guanosine at an equimolar concentration is added.


Subject(s)
Ribavirin/pharmacology , Ribonucleosides/pharmacology , Vaccinia virus/growth & development , Cell Line , Cytoplasm/metabolism , DNA, Viral/biosynthesis , Deoxyribonucleases/metabolism , Drug Antagonism , Guanosine/pharmacology , Peptide Biosynthesis , Vaccinia virus/metabolism , Viral Proteins/biosynthesis , Virus Replication/drug effects
6.
J Gen Virol ; 31(1): 125-9, 1976 Apr.
Article in English | MEDLINE | ID: mdl-177724

ABSTRACT

Tilorone hydrochloride, at a concentration of 10 mug/ml inhibits the growth of herpes simplex virus type 1 in BS-C-1 cells. The growth of vaccinia virus in BS-C-1 cells is partially inhibited; however, six viruses containing RNA, including four members of the togavirus group grown in chick fibroblasts, are not affected by the drug. The inhibition of the growth of herpes virus by tilorone hydrochloride is greater when the multiplicity of infection is lower than 1 p.f.u/cell and when the drug is added early in the course of infection.


Subject(s)
DNA Viruses/growth & development , Fluorenes/pharmacology , RNA Viruses/growth & development , Tilorone/pharmacology , Cell Line , Chemical Phenomena , Chemistry , Culture Techniques , DNA Viruses/drug effects , Encephalitis Virus, Eastern Equine/growth & development , Encephalitis Virus, Western Equine/growth & development , Poliovirus/growth & development , RNA Viruses/drug effects , Semliki forest virus/growth & development , Simplexvirus/growth & development , Sindbis Virus/growth & development , Vaccinia virus/growth & development
7.
Antimicrob Agents Chemother ; 9(1): 189-95, 1976 Jan.
Article in English | MEDLINE | ID: mdl-176928

ABSTRACT

Tilorone hydrochloride at a concentration of 10 mug/ml very efficiently inhibited herpes simplex virus growth in BSC1 cells when the virus is infected at a low multiplicity of infection. The adsorption of the virus was not affected by the drug, and the penetration of the deoxyribonucleic acid of the input virus into the cytoplasm and nuclei proceeded normally when tilorone hydrochloride was present. However, newly synthesized viral deoxyribonucleic acid was not detectable under these conditions, there was a remarkable decrease in the rate of viral polypeptide synthesis, and virus particles were not formed. The inhibition of herpesvirus growth by tilorone hydrochloride was absolutely dependent on the presence of the drug in the cultures. Pretreatment of the cells with the drug did not result in resistance to herpesvirus infection after the removal of the drug.


Subject(s)
DNA, Viral/biosynthesis , Fluorenes/pharmacology , Simplexvirus/metabolism , Tilorone/pharmacology , Viral Proteins/biosynthesis , Cell Nucleus/microbiology , Cells, Cultured , Cytoplasm/microbiology , Depression, Chemical , Methionine/metabolism , Virus Replication/drug effects
9.
Antimicrob Agents Chemother ; 7(5): 717-8, 1975 May.
Article in English | MEDLINE | ID: mdl-167659

ABSTRACT

Three acyl derivatives of amino acids, dicarbobenzoxy-l-lysine sodium, carbobenzoxy-l-aspartic acid-beta-benzyl ester potassium, and N-3-phenylpropionyl-S-benzyl-l-cysteine potassium inhibit the growth of parainfluenza 1 (hemadsorption 2) virus. The growth of simian virus 40, vaccinia, poliomyelitis type 1, Semliki Forest, Eastern equine encephalitis, and Western equine encephalitis viruses was not affected by these compounds. Four other acyl derivatives of amino acids did not inhibit the growth of any of the viruses tested.


Subject(s)
Amino Acids/pharmacology , Parainfluenza Virus 1, Human/growth & development , Depression, Chemical , Parainfluenza Virus 1, Human/drug effects , Time Factors
10.
Antimicrob Agents Chemother ; 7(1): 85-90, 1975 Jan.
Article in English | MEDLINE | ID: mdl-1137362

ABSTRACT

gamma-Thiochromanone-4-thiosemicarbazone (TCT) inhibits the growth of vaccinia virus in BSCl cells by interfering with viral maturation. A mutant of the virus (TCT(R)) which is resistant to this drug was isolated. This mutant also exhibits resistance to another thiosemicarbazone related compound, isatin beta-thiosemicarbazone (IBT). There is a good correlation between the cross-resistance of the two mutants IBT(R) and TCT(R) to TCT and IBT, respectively, and the similar antipoxvirus activity of these two thiosemicarbazone-related compounds.


Subject(s)
Benzopyrans/pharmacology , Chromans/pharmacology , Drug Resistance, Microbial , Thiosemicarbazones/pharmacology , Vaccinia virus/drug effects , Humans , Mutation , Sulfur , Vaccinia virus/immunology , Vaccinia virus/isolation & purification , Viral Proteins/biosynthesis
11.
Antimicrob Agents Chemother ; 6(5): 647-50, 1974 Nov.
Article in English | MEDLINE | ID: mdl-15825321

ABSTRACT

Hydroxyurea (5 x 10(-3) M) inhibits the development of vaccinia virus in HeLa cells early after infection and prevents the synthesis of viral deoxyribonucleic acid. In the presence of hydroxyurea, late viral polypeptides are not formed, as observed by electrophoresis on polyacrylamide gels.


Subject(s)
Hydroxyurea/pharmacology , Peptide Biosynthesis/drug effects , Vaccinia virus/drug effects , Viral Proteins/biosynthesis , DNA, Viral/biosynthesis , Dose-Response Relationship, Drug , HeLa Cells , Humans , Vaccinia virus/metabolism
15.
Antimicrob Agents Chemother ; 4(1): 44-8, 1973 Jul.
Article in English | MEDLINE | ID: mdl-4791481

ABSTRACT

Isatin-beta-thiosemicarbazone (IBT) at a concentration of 14 muM inhibited the multiplication of vaccinia virus in HeLa cells. For the first 3 h after infection, viral deoxyribonucleic acid (DNA) was synthesized in the presence of IBT at the same rate as in the control culture; the replication rate declined at a later stage. The DNA failed to be coated with proteins and to become resistant to deoxyribonuclease unless IBT was removed. "Early" and "late" viral polypeptides were formed in the presence of IBT, as revealed by polyacrylamide gel electrophoresis. The formation from precursor of a core polypeptide, a reaction blocked by rifampin, was not affected by IBT. Therefore, it is suggested that a maturation step later than the one blocked by rifampin is involved in the inhibition of vaccinia virus by IBT.


Subject(s)
Indoles/pharmacology , Peptide Biosynthesis , Thiosemicarbazones/pharmacology , Vaccinia virus/metabolism , DNA, Viral/biosynthesis , Female , HeLa Cells , Humans , Viral Proteins/biosynthesis , Virus Replication/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...